3 recruiting, 2 unknown, 1 completed. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 2, Unknown 1 |
Follow Trastuzumab: new trials by email Literature Review of Trastuzumab trials Research Report on Trastuzumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab Cardiovascular Health Education and Gaming through Virtual Reality - Breast Cancer, Anthracycline Related Cardiotoxicity in Breast Cancer | Not applicable | Recruiting | Virginia Commonwealth University | 30 | 2026-05-20 | 2026-09-22 |
| RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study Trastuzumab deruxtecan (DS-8201a) - Radiomic, Radiomics | Recruiting | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 500 | 2024-02-01 | 2025-06-22 | |
| Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer Chest wall / breast radiation with or without lymph node region radiation.(For all of the enrolled patients) - Breast Cancer, Familial Male, Radiotherapy; Complications | Not applicable | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 148 | 2024-01-12 | 2024-08-21 |
| Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients Taxane - HER2-positive Gastric Cancer, Metastatic Cancer | Completed | Centre Hospitalier Universitaire de Besancon | 65 | 2021-04-01 | 2021-06-10 | |
| Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer Candesartan - Cardiotoxicity, Breast Cancer | Not applicable | Unknown | Samsung Medical Center | 136 | 2019-07-19 | 2020-06-12 |
| Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab Trastuzumab - Cardiotoxicity, Antitumor Drugs | Unknown | Peking University Third Hospital | 30 | 2019-07-05 | 2021-07-14 |
Breast Neoplasms (5) · Cardiotoxicity (2) · Breast Cancer, Familial Male (1) · Neoplasm Metastasis (1)
Neoplasms (6) · Breast Diseases (5) · Neoplasms by Site (5) · Skin Diseases (5) · Skin and Connective Tissue Diseases (5) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Cardiovascular Diseases (2) · Chemically-Induced Disorders (2) · Drug-Related Side Effects and Adverse Reactions (2) · Heart Diseases (2) · Radiation Injuries (2) · Wounds and Injuries (2) · Neoplastic Processes (1)
Trastuzumab (1) · candesartan (1) · taxane (1) · trastuzumab deruxtecan (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Centre Hospitalier Universitaire de Besancon (1) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Peking University Third Hospital (1) · Samsung Medical Center (1) · Virginia Commonwealth University (1)
China (2) · France (1) · Italy (1) · South Korea (1) · United States (1)
Arnethea Sutton, Ph.D (1) · Bo Lan, MD (1) · Fei Ma, MD (1) · Shulian Wang, MD (1) · Yirui Zhai, MD (1)
PMID 28581356, PMID 28968163, PMID 34081848, PMID 35020465, PMID 35340264